| PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial FJ Raal, EA Stein, R Dufour, T Turner, F Civeira, L Burgess, G Langslet, ... The Lancet 385 (9965), 331-340, 2015 | 871 | 2015 |
| Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumab E Stroes, D Colquhoun, D Sullivan, F Civeira, RS Rosenson, GF Watts, ... Journal of the American College of Cardiology 63 (23), 2541-2548, 2014 | 681 | 2014 |
| Cardiovascular efficacy and safety of bococizumab in high-risk patients PM Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, ... New England Journal of Medicine 376 (16), 1527-1539, 2017 | 654 | 2017 |
| Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia F Civeira, ... Atherosclerosis 173 (1), 55-68, 2004 | 647 | 2004 |
| ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia JJP Kastelein, HN Ginsberg, G Langslet, GK Hovingh, R Ceska, R Dufour, ... European heart journal 36 (43), 2996-3003, 2015 | 628 | 2015 |
| Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (Progression of Early Subclinical … L Fernández-Friera, JL Peñalvo, A Fernández-Ortiz, B Ibañez, ... Circulation 131 (24), 2104-2113, 2015 | 527 | 2015 |
| Volanesorsen and triglyceride levels in familial chylomicronemia syndrome JL Witztum, D Gaudet, SD Freedman, VJ Alexander, A Digenio, ... New England Journal of Medicine 381 (6), 531-542, 2019 | 425 | 2019 |
| Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term … MJ Koren, RP Giugliano, FJ Raal, D Sullivan, M Bolognese, G Langslet, ... Circulation 129 (2), 234-243, 2014 | 326 | 2014 |
| Homozygous Tangier disease and cardiovascular disease C Serfaty-Lacrosniere, F Civeira, A Lanzberg, P Isaia, J Berg, ED Janus, ... Atherosclerosis 107 (1), 85-98, 1994 | 302 | 1994 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 248 | 2019 |
| Femoral and carotid subclinical atherosclerosis association with risk factors and coronary calcium: the AWHS study M Laclaustra, JA Casasnovas, A Fernández-Ortiz, V Fuster, M León-Latre, ... Journal of the American college of cardiology 67 (11), 1263-1274, 2016 | 240 | 2016 |
| A third major locus for autosomal dominant hypercholesterolemia maps to 1p34. 1-p32 M Varret, JP Rabes, B Saint-Jore, A Cenarro, JC Marinoni, F Civeira, ... The American journal of human genetics 64 (5), 1378-1387, 1999 | 234 | 1999 |
| Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia F Civeira, E Ros, E Jarauta, N Plana, D Zambon, J Puzo, JPM de Esteban, ... The American journal of cardiology 102 (9), 1187-1193. e1, 2008 | 219 | 2008 |
| Familial apolipoprotein AI, C-III, and A-IV deficiency and premature atherosclerosis due to deletion of a gene complex on chromosome 11 JM Ordovas, DK Cassidy, F Civeira, CL Bisgaier, EJ Schaefer Journal of Biological Chemistry 264 (28), 16339-16342, 1989 | 200 | 1989 |
| Restriction fragment length polymorphisms of the apolipoprotein AI, C-III, A-IV gene locus Relationships with lipids, apolipoproteins, and premature coronary artery disease JM Ordovas, F Civeira, J Genest Jr, S Craig, AH Robbins, T Meade, ... Atherosclerosis 87 (1), 75-86, 1991 | 180 | 1991 |
| Impaired sensitivity to thyroid hormones is associated with diabetes and metabolic syndrome M Laclaustra, B Moreno-Franco, JM Lou-Bonafonte, R Mateo-Gallego, ... Diabetes Care 42 (2), 303-310, 2019 | 163 | 2019 |
| Serum chitotriosidase activity is increased in subjects with atherosclerosis disease M Artieda, A Cenarro, A Gañán, I Jericó, C Gonzalvo, JM Casado, I Vitoria, ... Arteriosclerosis, thrombosis, and vascular biology 23 (9), 1645-1652, 2003 | 160 | 2003 |
| Higher incidence of mild cognitive impairment in familial hypercholesterolemia D Zambón, M Quintana, P Mata, R Alonso, J Benavent, F Cruz-Sánchez, ... The American journal of medicine 123 (3), 267-274, 2010 | 157 | 2010 |
| A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia A Cenarro, M Artieda, S Castillo, P Mozas, G Reyes, D Tejedor, R Alonso, ... Journal of medical genetics 40 (3), 163-168, 2003 | 152 | 2003 |
| Association study of schizophrenia with polymorphisms at six candidate genes C Virgos, L Martorell, J Valero, F Civeira, J Joven, A Labad, E Vilella, ... Schizophrenia research 49 (1-2), 65-71, 2001 | 150 | 2001 |
